Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome |
| |
| Authors: | Julija Č iauš kaitė ,Ieva Puleikytė ,Simonas Jesmanas,Giedrė Jurkevič ienė ,Antanas Vaitkus,Daiva Rastenytė |
| |
| Affiliation: | 1. Department of Neurology, Medical Academy, Lithuanian University of Health Sciences, Kaunas Lithuania ; 2. Department of Radiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas Lithuania |
| |
| Abstract: | ![]()
Creutzfeldt‐Jakob disease (CJD) is a rare rapidly progressive fatal neurodegenerative disease. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which may be used to treat neuropsychiatric symptoms of CJD. We present a case of a 51‐year‐ old woman with CJD who developed NMS after being prescribed quetiapine. |
| |
| Keywords: | atypical antipsychotic medications, Creutzfeldt‐ Jakob disease, electroencephalography, magnetic resonance imaging, neuroleptic malignant syndrome, quetiapine |
|
|
